Peer review reports
From: AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
| Original Submission | ||
|---|---|---|
| 8 Jul 2022 | Submitted | Original manuscript |
| 5 Aug 2022 | Reviewed | Reviewer Report - Prerna Raina |
| 28 Sep 2022 | Reviewed | Reviewer Report |
| 15 Oct 2022 | Author responded | Author comments - Ze-fang Ren |
| Resubmission - Version 2 | ||
| 15 Oct 2022 | Submitted | Manuscript version 2 |
| 31 Oct 2022 | Reviewed | Reviewer Report |
| 3 Feb 2023 | Reviewed | Reviewer Report |
| 16 Feb 2023 | Author responded | Author comments - Ze-fang Ren |
| Resubmission - Version 3 | ||
| 16 Feb 2023 | Submitted | Manuscript version 3 |
| 26 Apr 2023 | Reviewed | Reviewer Report |
| 6 May 2023 | Author responded | Author comments - Ze-fang Ren |
| Resubmission - Version 4 | ||
| 6 May 2023 | Submitted | Manuscript version 4 |
| 9 May 2023 | Author responded | Author comments - Ze-fang Ren |
| Resubmission - Version 5 | ||
| 9 May 2023 | Submitted | Manuscript version 5 |
| 12 May 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 16 May 2023 | Editorially accepted | |
| 11 Aug 2023 | Article published | 10.1186/s12885-023-10964-6 |